A researcher is looking at the effects of a new drug for treating time to relief from an asthma attack. He recruits 15 asthma patients, and randomizes them to one of two study groups. The control group receives an inhaler with a standard asthma medicine. The experimental group receives an inhaler containing the new drug. The researcher collects time to relief and then follows the patients for six months and collects time to relief again. The data below represent the time to relief, in seconds, at baseline and six-month follow-up for all patients: Grou- Baseline in s Follow-u in 5 Control Control Control Control Control Control Control Control Control Control Ex-eriment Exneriment _ Experiment Exneriment 15 . Experiment _ 16 16 l' H C CD |\\J H M ED LU H C CD M O CO H LU |L D L0 H \\J [1 LL] l' C) H O |L D l' H 03 U1 tI-tt WM tttttI U'INJCD II-Il NUJ ._| .h. CD The researcher would like to use this data to answer four specific questions: 1. Is there a difference between the two groups on their baseline time to relief measures